Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

INVEGA TRINZA® (paliperidone palmitate)

Medical Information

+ Save link

Latex Content of INVEGA SUSTENNA, INVEGA TRINZA and INVEGA HAFYERA

Last Updated: 06/18/2024

UNPUBLISHED DATA ON FILE

To our knowledge, the materials used in the production of INVEGA SUSTENNA^®, INVEGA TRINZA^®, and INVEGA HAFYERA^® syringe components (also referred to as packaging materials) do not contain latex/synthetic rubber as an ingredient; however, we cannot guarantee that the materials do not come in contact with latex/synthetic rubber during the manufacturing or packaging process (e.g. latex gloves).¹^,²

PUBLISHED LITERATURE

A literature search of MEDLINE^®, EMBASE^®, BIOSIS Previews^®, and DERWENT Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 16 May 2024.

References

Show

1	Data on File. INVEGA SUSTENNA (paliperidone palmitate) - Patient Safety and Compliance Information of Excipients (EXC) and Immediate Containers (IMC); 2020.
2	Data on File. INVEGA TRINZA/TREVICTA/INVEGA HAFYERA (paliperidone palmitate) - Patient Safety and Compliance Information of Excipients (EXC) and Immediate Containers (IMC); 2021.